Abstract
Habitual marijuna use may lead to the following effects on the lung: acute and chronic bronchitis; extensive microscopic abnormalities in the cells lining the bronchial passages, some of which may be premalignant; overexpression of molecular markers of progression to lung cancer in bronchial tissue; abnormally increased accumulation of inflammatory cells (alveolar macrophages) in the lung; and impairment in the function of these immune-effector cells (reduced ability to kill microorganisms and tumor cells) and in their ability to produce protective inflammatory cytokines. Clinically, the major pulmonary consequences that may ensue from regular marijuana use are pulmonary infections and respiratory cancer. Infections of the lung are more likely in marijuana users because of a combination of smoking-related damage to the ciliated cells in the bronchial passages (the lung’s first line of defense against inhaled microorganisms) and marijuana-related impairment in the function of alveolar macrophages (the principal immune cells in the lung responsible for defending it against infection). Patients with pre-existing immune deficits caused by AIDS or cancer chemotherapy might be expected to be particularly vulnerable to marijuana-related pulmonary infections. Furthermore, biochemical, cellular, genetic, animal, and human studies all suggest that marijuana is an important risk factor for the development of respiratory cancer. However, proof that habitual use of marijuana does in fact lead to respiratory cancer must await the results of well-designed case-control epidemiologic studies that should now be feasible after the passage of 30 years since the inititation of widespread marijuana use among young individuals in our society in the mid-1960s.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hoffmann, D., Brunneman, D. K., Gori, G. B., and Wynder, E. L. (1975) On the carcinogenicity of marijuana smoke. Recent. Adv. Phytochem. 9, 63–81.
Novotny, M., Lee, M. L., and Bartle, K. D. (1976) A possible chemical basis for the higher mutagenicity of marijuana smoke as compared to tobacco smoke. Experientia. 32, 280–282.
Dinissenko, M. F., Pao, A., Tang, M-S, and Pfeifer, G. P. (1996) Preferential formation of benz[ajpyrene adducts at lung cancer mutational hotspots in p53. Science 274, 430–32.
Roy, P. E., Magnan-Lapointe, F., Huy, N. D., and Boutet, M. (1976) Chronic inhalation of marijuana and tobacco in drugs: pulmonary pathology. Research Communications in Chemical Pathology and Phamacology. 14: 305–307.
Fligiel, S. E. G., Beals, T. F., Tashkin, D. P., Paule, M. G., Scallet, A. C., Ali SF, Bailey JR, and Slikker W Jr. (1991) Marijuana exposure and pulmonary alterations in primates. Pharmacol. Biochem. Behay. 40, 637–642.
Fleischman, R. W., Baker, J. R., and Rosenkrantz, H. (1979) Pulmonary pathologic changes in rats exposed to marijuana smoke for one year. Toxicol. Appl. Pharmacol. 47, 557–566.
Rosenkrantz, H. and Fleischman, R. W. (1979) Effects of cannabis on lung. In: Nahas, G. and Payton, W. D. H. (eds.) Marijuana: Biological Effects. Oxford, England, Pergamon Press, pp. 279–299.
Huber, G. L, Mahajan, V. K. (1988) The comparative response of the lung to marihuana or tobacco smoke inhalation. In: Marijuana: An International Research Report. Proceedings of Melbourne Symposium on Cannabis 2–4 September, 1987. (Cheser G, Consroe P, Musty R., eds.) National Campaign Against Drug Abuse. Monograph Series No. 7, Australian Government Publishing Service, Canberra, pp. 19–24.
Chopra, G. S. (1973) Studies on psycho-clinical aspects of long-term marihuana use in 124 cases. Int. J. Addict. 8, 1015–1026.
Hall, J. A. S. (1975) Testimony in marijuana-hashish epidemic and its impact on United States security, In: Hearings of the Committee on the Judiciary, United States Senate. Government Printing Office, pp. 147–154.
Rubin, V. and Comitas, L. (1975) Respiratory function and hematology. In: Ganja in Jamaica: A Medical Anthropological Study of Chronic Marihuana Use. The Hague, Mouton, pp. 87–102.
Boulougouris, J. C., Panayiotopoulos, C. P., Antypas, E, Liakos, A., and Stefanis, C. (1976) Effects of chronic hashish use on medical status in 44 users compared with 38 controls. Ann. NYAcad. Sci. 282, 168–172.
Tashkin, D. P., Coulson, A. H., Clark, V A, Simmons, M., Bourque, L. B., Duann, S., Spivey, G. H., and Gong, H: Respiratory symptoms and lung function in habitual, heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am. Rev. Respir Dis. 135, 209–216.
Bloom, J. W., Kaltenborn, W. T., Paoletti, P., Camilli, A., and Lebowitz, M. S. (1987) Respiratory effects of non-tobacco cigarettes. Br. Med. J. 295, 516–518.
Tashkin, D. P., Simmons, M. S., Sherrill, D., and Coulson, A. H. Heavy habitual marijuana smoking does not cause an accelerated decline in FEVI with age: a longitudinal study. Am. J. Respir. Crit. Care Med. 155, 141–148.
Gong, H. Jr, Fligiel, S., Tashkin, D. P., and Barbers, R. G. (1987) Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am. Rev. Respir. Dis. 136, 142–149.
Fligiel, S. E. G, Roth, M. D., Kleerup, E. C., Barsky, S. H., Simmons, M. S., and Tashkin, D. P. (1997) Tracheobronchial histopathology in habitual smokers of cocaine, marijuana and/or tobacco. Chest. 112, 319–326.
Roth, M. D., Kleerup, E. C., Arora, A., Barsky, S., and Tashkin, D. P. (1998) Airway inflammation in young marijuana and tobacco smokers. Am. Rev. Respir. Crit. Care Med. 157, 928–937.
Auerbach, O., Stout, A. P. Hammond, E. D.,and Garfinkel, L. (1961) Changes in bronchial epithleium in relation to cigarette smoking and its relation to lung cancer. N. Engl. J. Med. 265, 253–267.
Tennant, F. S. Jr. (1980) Histopathologic and clinical abnormalities of the respiratory system in chronic hashish smokers. Subst. Alcohol. Actions Misuse 1, 93–100.
Barsky, S. H., Roth, M. D., Kleerup, E. C., Simmon, M., and Tashkin, D. P. (1998) Molecular alterations in bronchial epithelium of habitual smokers of marijuana, cocaine and/or tobacco. J. Natl. Cancer Inst. (in press).
Barbers, R. G., Gong, H. Jr, Tashkin, D. P., Oishi, J., and Wallace, J. M. (1987) Differential examination of bronchoalveolar lavage cells in tobacco cigarette and marijuana smokers. Am. Rev. Respir. Dis. 135, 1271–1275.
Beals, T. F., Fligiel, S. E. G., Stuth, S., and Tashkin, D. P. (1989) Morphological alterations of alveolar macrophages from marijuana smokers. Am. Rev. Respir. Dis. 139 (Part 2), A336.
Sherman, M. P., Campbell, L. A., Gong, H. Jr, Roth, M. D., and Tashkin, D. P. (1991) Respiratory burst and microbicidal characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco and nonsmokers. Am. Rev. Respir. Dis. 144, 1351–1356.
Baldwin, G. C., Tashkin, D. P., Buckley, D. M., Park, A. N., Dubinett, S. M., and Roth, M. D. (1997)Habitual smoking of marijuana and cocaine impairs alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care. Med. 156, 1606–1613.
Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Delpech, B., Shire, D., LeFur, G., and Casellas, P. (1993) Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214, 173–80.
Huber, G. L., Simmons, G. A., McCarthy, C. R.,Cutting, M. B., Laguarda, R., and Pereira, W. (1975) Depressant effect of marihuana smoke on antibactericidal activity of pulmonary alveolar macrophages. Chest. 68, 769–773.
Huber, G. L., Pochay, V. E., Pereira, W., Shea, J. W., Hinds, W. C., First, M. W., and Sornberger, G. C. (1980) Marijuana, tetrahydrocannabinol, and pulmonary antibacterial defenses. Chest 77, 403–410.
Klein, T. S., Kawakami, Y., Newton, C., and Friedman, H. (1991) Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. J. Toxicol. Environ. Health. 32, 465–77.
Kusher, D. I., Dawson, L. O., Taylor, A. C., and Djeu, J. Y. (1994) Effect of the psychoactive metabolite of marijuana, delta-9-tetrahydrocannabinol (THC), on synthesis of tumor necrosis factor by human large granular lymphocytes. Cellular Immunol. 154, 99–108.
Tindall, B. Philipot, C. R., Cooper, D. A., Gold, J., Donovan, B., Penny, R., and Barnes, T. (1988) The Sydney AIDS project: Development of acquired immune deficiency syndrome in a group of HIV seropositive homosexual men. Aust. NZ J. Med.
Newton, C. A., Klein, T. W., and Friedman, H. (1994) Secondary immunity to Legionella pneumophilia and Thl activity are suppressed by 09-tetrahydrocannabinol injection. Infection and Immun. 62, 4015–20.
Denning, D. W., Follansbee, S. E., Scolaro, M., Norris, S., Edelstein, H., and Stevens, D. A. (1991) Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324, 654–662.
Caiaffa, W. T., Vlahov, D., Graham, N. M., Astemborski, J., Solomon, L., Nelson, K. E., and Munoz, A. (1994) Drug smoking, Pneumocystis carinii pneumonia, and immunosuppresion increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive infection drug users. Am. Rev. Respir. Dis. 150, 1493–1498.
Newell, G. R., Mansell, P. W., Wilson, M. B., Lynch, H. K., Spitz, M. R., and Hersh, E. M. (1985) Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Preventive Medicine 14, 81–91.
Tindall, B., Philipot, C. R., Cooper, D. A., gold, J., Donuvan, B., Penny, R., and Barnes, T. (1988) The Sydney AIDS project: Development of acquired immune deficiency syndrome in a group of HIV seropositive homosexual men. Aust. NZ J. Med.
Wu, T-C, Tashkin, D. P., Djahed, B., and Rose, J. E. (1988) Pulmonary hazards of smoking marijuana as compared with tobacco. N. Engl. J. Med. 318, 347–351.
Marques–Magallanes, J. A., Tashkin, D. P., Serafian, T., Stegeman, J., and Roth, M. D. (1997) In vivo and in vitro activation of cytochrome P4501A1 by marijuana smoke. Presented by DP Tashkin at the 1997 Symposium on the Cannabinoids of the International Cannabinoid Research Society, Stone Mountain, GA, June, 1997, International Cannabinoid Research Society Program and Abstracts, ISBN# 09658053–0–1, p.78.
Wehner, F. C., Van Rensburg, S. J., and Theil, P. F. (1980) Mutagenicity of marijuana and Transkei tobacco smoke condensates in the Salmonella/microsome assay. Mutat. Res. 77, 135–142.
Cottrell (1973)
Leuchtenberger, C., and Leuchtenberger, R. (1976) Cytological and cytochemical studies of the effects of fresh marihuana cigarette smoke on growth and DNA metabolism of animal and human lung cultures. In: The Pharmacology of Marijuana ( Braude MC, Szara S eds.). Raven, New York, p. 595–612.
Roth, M. D., Zhu, L., Sharma, S., Stolina, M., Park, A. N., Chen, K., Tashkin, D. P., and Dubinett, S. M. (1997) L9–tetrahydrocannabinol inhibits antigen–presentation in vitro and anti–tumor immunity in vivo. Presented at the 1997 Symposium on the Cannabinoids of the International Cannabinoid Research Society, Stone Mountain, GA, June, 1997, International Cannabinoid Research Society Program and Abstracts, ISBN# 09658053–0–1, p. 79.
Zhu, L., Sharma, S., Stolina, M., Chen, K., Park, A., Roth, M., Tashkin, D. P., and Dubinett, S. M. (1997) THC-mediated inhibition of the antitumor immune response. Presented at the 19th Southern California Pulmonary Research Conference, Palm Springs, CA, January.
Taylor, F. M. III. (1988) Marijuana as a potential respiratory tract carcinogen: A retrospective analysis of a community hospital population. South. Med. J. 81, 1213–1216.
Sridhar, K. S., Raub, W. A., Weatherby, N. L., Metsch, L. R., Surratt, H. L., Inciardi, J. A., Duncan, R. C., Anwyl, R. S., and McCoy, C. B. (1994) Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. J. Psychoactive Drugs 26, 285–88.
Donald, P. J. (1991) Advanced malignancy in the young marijuana smoker. Adv. Exp. Med. Biol. 288, 33–46. 46. USDHEW. (1979)Smoking and Health. A Report of the Surgeon General. DHEW Publication No.(PHS) 7950066. Washington, DC: USGPO.
Endicott, J. N., Skipper, P., and Hernandez, L. (1993) Marijuana and head and neck cancer. Adv. Exp. Med. Biol. 335, 107–113.
Sidney, S., Beck, J. E., Tekawa, I. S., and Quesenberry, C. P., Jr. (1997) Marijuana use and cancer incidence. Am. J. Public Health 585–590.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tashkin, D.P. (1999). Marihuana and the Lung. In: Nahas, G.G., Sutin, K.M., Harvey, D., Agurell, S., Pace, N., Cancro, R. (eds) Marihuana and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-710-9_28
Download citation
DOI: https://doi.org/10.1007/978-1-59259-710-9_28
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5717-0
Online ISBN: 978-1-59259-710-9
eBook Packages: Springer Book Archive